logo-altasciences

EN - Main navigation

  • Proactive Drug Development
  • Solutions
  • Compare Us
  • Facilities
  • About Us
  • Resource Center
  • Careers
  • News & Events
  • Contact Us
  • Participate in a study
Français
  • Home
  • Current: CEO’s Corner

CEO’s Corner

With each business quarter comes an opportunity for our CEO to reflect on the past, the present, and the future of Altasciences. Read Chris' special message to you below.

Share this page

Winter 2024

Here we are, at the end of 2024! I want to take a moment to express my heartfelt gratitude for the incredible year we’ve had together, and for the trust you continue to place in Altasciences.

Your innovation and dedication to life-saving therapeutics have propelled us to extraordinary milestones together, and they fueled a busy year here at Altasciences. And that’s how we like it.

Thank you for your relentless pursuit of a healthier world.

And thank you to our talented and passionate Altascientists; you make Altasciences a remarkable company and a fun place to work, and for that, I am deeply grateful.

I look forward to an exciting New Year! 

The name "Chris" written in handwriting font

Happy Holidays

Highlights

  • Webinars and Podcasts
    All of our newsletters in one place. Catch up on the latest at Altasciences.
  • Innovation Home Brewed
  • Imagine partnering with an integrated team you can trust, and telling your story once.
  • Watch this video to discover Proactive Drug Development with Altasciences.
  • In this Quick Chat, I get candid about Altasciences’ leadership style, culture, and organizational structure.
  • In this interview, I discuss Altasciences' one operational structure, and how it addresses a major challenge within the drug development industry.
  • Chris Perkin
    Read my interview with CIOReview about how Altasciences is simplifying the outsourcing paradigm for early phase drug development.
  • PharmaVoice 100
    Read my interview with Pharma Voice about transforming the industry with a people-focused approach.

Sign up for exclusive content

Join our list of 10,000+ VIP members and have access to our exclusive content.

Stay connected

  • linkedin
  • youtube

Footer

    • Solutions

      • Preclinical Services
      • Clinical Services
      • Manufacturing and Analytical Services
      • Bioanalytical Services
      • Research Support Services
      • Development Programs
    • News & Events

      • Altasciences Events
      • Press Releases
      • Altasciences in the News
      • Press Kit
    • Resource Center

      • The Altascientist
      • Webinars/Podcasts
      • Newsletters
      • Scientific Publications
      • Blog
      • Videos
    • Study Types

      • Preclinical
      • Lead Optimization
      • Pharmacology
      • Pharmacokinetics/​Pharmacodynamics
      • Acute Toxicology
      • Dose Range Finding​/​Maximum Tolerated Dose
      • Repeated Dose Toxicity
      • Safety Pharmacology
      • Sub-Chronic/Chronic, Repeated Dose Toxicity
      • Clinical
      • First in Human
      • Proof of Concept
      • Bioavailability/Bioequivalence
      • Pharmacokinetics in Special Populations
      • Human Abuse Potential
      • Driving Simulation
      • Drug-Drug Interaction
      • QT Assessment
      • Renal and Hepatic Impaired
      • Imaging
      • Biologics​/​Biosimilars
    • Therapeutic Areas

      • Cardiology
      • Dermatology
      • Gastroenterology
      • Hematology
      • Immunology
      • Infectious Diseases
      • Metabolism and Endocrinology
      • Neurology
      • Oncology
      • Ophthalmology
      • Orthopedics
      • Psychiatry
      • Respirology
      • Rheumatology
      • Substance Abuse
      • Urology
      • Women’s Health
    • About us

      • History
      • Our Origins
      • Awards
      • Testimonials
    • Careers

    • Contact Us

    • Locations

    • Stay connected

      • Facebook
      • Youtube

2025 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy

Have a question?

I'd be happy to help.

Captcha is required.